Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Oragenics, Inc. (OGEN : AMEX)
 
 • Company Description   
Oragenics Inc is a biotechnology company focused on the development and licensure of innovative products and technologies for improving human health.

Number of Employees: 5

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.26 Daily Weekly Monthly
20 Day Moving Average: 488,912 shares
Shares Outstanding: 116.39 (millions)
Market Capitalization: $30.26 (millions)
Beta: 0.12
52 Week High: $1.15
52 Week Low: $0.22
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -28.33% -21.48%
12 Week -33.71% -28.07%
Year To Date -41.70% -30.68%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
4902 EISENHOWER BOULEVARD SUITE 125
-
TAMPA,FL 33634
USA
ph: 813-286-7900
fax: 813-286-7904
tpatel@lhai.com http://www.oragenics.com
 
 • General Corporate Information   
Officers
Michael O. Sullivan - Interim Principal Executive Officer and Chief Fina
Frederick W. Telling - Chairman and Director
Robert C. Koski - Director
Charles L. Pope - Director
Alan W. Dunton - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 684023302
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/15/22
Share - Related Items
Shares Outstanding: 116.39
Most Recent Split Date: 1.00 (0.10:1)
Beta: 0.12
Market Capitalization: $30.26 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/15/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.69
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 0.00%
vs. Previous Quarter: -150.00%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -82.76%
ROE
03/31/22 - -67.68
12/31/21 - -55.53
09/30/21 - -72.01
ROA
03/31/22 - -56.61
12/31/21 - -47.63
09/30/21 - -58.27
Current Ratio
03/31/22 - 15.37
12/31/21 - 19.17
09/30/21 - 13.90
Quick Ratio
03/31/22 - -
12/31/21 - 19.17
09/30/21 - 13.90
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -16,202.94
12/31/21 - -18,062.47
09/30/21 - -
Book Value
03/31/22 - 0.15
12/31/21 - 0.20
09/30/21 - 0.22
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©